(The Hill) – Federal regulators shook up the booming weight loss drug marketplace ... Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions ...
For Pilar DeMann, being on semaglutide during perimenopause motivated her to prioritize whole foods, stay mindful of portion sizes, and scale back on alcohol.